Chemotherapy

Understanding and managing drug shortages in oncology

Jennifer Tobin, PharmD May 17, 2011

Disruptions in supply impact patient care. Nurses should know when to use a substitution drug and when to wait for the next shipment.
 

Managing asparaginase-related toxicity in adult patients

Barbara Tripp, MSN, CNS, AOCN January 14, 2011

Prompt management of symptoms is key to minimizing risk and maximizing tolerance of this antineoplastic agent.
 

Understanding the interaction between food and treatment

August 01, 2010

What, how much, and when patients eat, as well as dietary supplement use, impact the efficacy of cancer therapy.
 

Communication

Preparing family members to care for the patient at home

July 15, 2010

Outpatient treatment shortens hospital stays and shifts responsibility for patient care onto family members with no medical training.
 

After the cancer diagnosis: What do you say—and do—next?

May 01, 2010

The most important thing, say the experts interviewed for this article, is for oncology nurses to reassure patients that they are not alone.
 

End-of-Life Issues

The burden of care decisions: Helping surrogates follow through with patients' wishes

October 19, 2011

Surrogacy can be an overwhelming responsibility for a patients' friend or family member. Patients should carefully consider who they want to serve as a surrogate and include that person.
 

New models estimate survival time in advanced cancer

Delicia Honen Yard September 09, 2011

A number of variables can be used to estimate whether a person with advanced cancer who is no longer being treated for the disease will live for days, weeks, or months.
 

ASCO/ACS Award recognizes the role of palliative care in the continuum of cancer care

August 01, 2011

The recipient of the 2011 American Society of Clinical Oncologists/ American Cancer Society award is a pioneer in palliative medicine.
 

Pain Management

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

An exit strategy for opioid therapy

January 26, 2012

What exit strategy do you recommend for discontinuing opioid therapy?
 

Work-around: An indirect way to accomplish the same goal

December 19, 2011

Interpersonal relations are comparable to navigating computer software. A change in approach may produce the desired results.
 

Palliative Care

Should informed consent mean the patient understands?

January 30, 2012

The patient understood that surgery was the best next step in her treatment. Or, did she?
 

Oncologists need to sharpen their pain-management skills

Delicia Honen Yard November 25, 2011

The results of a recent survey suggest that pain-related knowledge and practice may not be up to par within the oncology community.
 

The burden of care decisions: Helping surrogates follow through with patients' wishes

October 19, 2011

Surrogacy can be an overwhelming responsibility for a patients' friend or family member. Patients should carefully consider who they want to serve as a surrogate and include that person.
 

Side-Effect Management

Distress: Measuring its relation to cancer diagnosis and treatment

Rosemarie A. Tucci, RN, MSN January 26, 2012

Nurses should assess cancer patients frequently and intervene promptly throughout the treatment course.
 

Using ESAs in patients with cancer-related anemia

Sarah Wenger, PharmD; Lisa A. Thompson, PharmD, BCOP January 13, 2012

Although the risks of erythropoietin-stimulating agents can outweigh the benefits, select patients may benefit from these drugs.
 

CIPN: Treatment preservation and prevention are the goals

Colleen H. Erb, MSN, ACNP-BC, AOCNP September 21, 2011

CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.
 

Survivorship

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

Identifying barriers to a successful cancer survivorship program

Kennon McCollum, RN, MSN, APRN-BC January 26, 2012

Recognition of factors that intercede with cancer survivors' care can overcome the obstacles that impede program success.
 

Survival Reduced for Patients With Cancer Who Have Diabetes

January 26, 2012

Type of cancer and diabetes treatment influence survival, according to a recent study.
 

What's New

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions